National Effort to Hasten Treatments for Those With Pancreatic Cancer Enrolling Patients at UF Health
A novel clinical trial platform that aims to accelerate treatment discoveries for people battling pancreatic cancer is now enrolling patients at 15 sites nationwide, including the University of Florida Health Cancer Center.
An initiative of the national nonprofit organization Pancreatic Cancer Action Network, or PanCAN, Precision PromiseSM began development in 2016. The UF Health Cancer Center is the only site in Florida participating in the novel clinical trial platform that hopes to ramp up treatments for patients with the aggressive form of cancer.
“A dedicated clinical trial with such innovation and flexibility, specifically for patients with pancreatic cancer, is long overdue,” said Thomas George, M.D., the study’s principal investigator at UF and associate director for clinical research at the UF Health Cancer Center. “We are thrilled to be able to offer this to the patients of Florida and the Southeast region of the U.S.”
Learn more about National Effort to Hasten Treatments for Those With Pancreatic Cancer Enrolling Patients at UF Health.